HealthQuill Pharma
Thermo Fisher Scientific to buy Solvemtum’s purification unit for $4.1 billion in cash
Drugs Medical Pharma

Thermo Fisher to buy Solventum’s filtration unit for $4.1 billion in cash

HQ Team March 1, 2025: Thermo Fisher Scientific Inc., will buy Solventum’s purification and filtration business for $4.1 billion in cash to support.

Read More
Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according to a statement.
Drugs Medical Pharma

Eli Lilly to set up four manufacturing facilities in US for $27 billion

Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according.

Read More
AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the Anglo-Swedish company.
Drugs Health Pharma

AstraZeneca says trial breast cancer drug improves survival rates

AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the.

Read More
Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats
Drugs Health Pharma

Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats

Eli Lilly and Company cut the prices of its weight-loss drug  Zepbound, available in single-dose vials, in a bid to end compounding companies from.

Read More
Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency for Research on Cancer, a specialised arm of the World Health Organization.
Drugs Health Pharma

Breast cancer death rates globally to rise 68% by 2050: WHO arm IARC warns

Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.

Read More
Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according to a company statement.
Health Medical Pharma

Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval

Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.

Read More
Saudi Arabia has reaffirmed a $500 million pledge to the WHO’s Global Polio Eradication Initiative to fight the disease plaguing vulnerable children, according to a statement.
Health Medical Pharma

Saudi Arabia reaffirms $500 million pledge to eradicate polio

Saudi Arabia has reaffirmed a $500 million pledge to the WHO’s Global Polio Eradication Initiative to fight the disease plaguing vulnerable children, according.

Read More
US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake in India’s HealthCare Global Enterprises Ltd. (HCG).
Health Medical Pharma

KKR to acquire majority stake in India’s HCG for $400 million

US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake.

Read More
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation” due to low morale, poor funding and a legitimacy crisis, a UN official said.
Health Medical Pharma

UN humanitarian aid system facing ‘greatest test’ since creation: Relief chief

The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation”.

Read More
FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing the Anglo-Swedish firm to gain access to an anaemia drug in the world’s most populated nation.
Drugs Health Pharma

AstraZeneca Plc buys China unit of FibroGen Inc for $160 million

HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.

Read More